DAYTONA BEACH, Fla.,
July 30, 2012 /PRNewswire/ --
Quture International, Inc. (OTCQB: TCLN) and
its operations subsidiary Quture, Inc. ("Quture") today
announces the successful completion of electronic clinical data
capture at Niagara Falls Memorial Medical Center (NFMMC),
Niagara Falls, New York, for the
interdisciplinary QualOptima product. The QualOptima analytics
system will determine return on investment (ROI) for commercial
sales to hospitals and other potential customers. ROI analytics are
scheduled for completion on August
31.
The partnership between Quture and InterSystems Corporation
(Cambridge, MA) and ExcelCare,
Inc. (Ligonier, PA) will complete
the return on investment analysis for commercial sales,
supplementing physician performance analytics at the University of Miami. Nursing data from Quture's
strategic alliance with ExcelCare exponentially enhances the
performance measurement value of the product. The benefit of
QualOptima to improve care while reducing costs targets the
prevention of Hospital Acquired Conditions (HAC). Overall, the
costs to treat patients who experience these preventable conditions
were over $22 billion in 2007 alone.
CMS and Medicare are aggressively withholding reimbursement for
treatment of patients who acquire these conditions in hospitals,
totaling millions of dollars annually and growing at the rate of
20% annually.
NFMMC is a long-established customer of ExcelCare providing an
extraordinary clinical setting to transform manual data collection
to electronic data capture on the InterSystems platform. The NFMCC
project has implemented an evidence-based optimal clinical process
for on prevention of catheter-acquired urinary tract infections
(CAUTI) in the intensive care unit. This clinical condition was
selected as an example of Hospital Acquired Conditions (HAC), which
is one of several federal initiatives of the Centers for Medicare
and Medical Services (CMS) targeted for significant payment
reductions. The ROI analysis is focused on payment initiatives,
such as Accountable Care Organizations (ACO) as well as value-based
purchasing.
Landon Feazell, Chairman and CEO
of Quture, in collaboration with Dr. Judith
Daugherty, President & CEO of ExcelCare said: "We are
committed to integrating nursing and physician clinical performance
for measurement and analytics. For hospitals to be competitive,
profitable, and meet federal mandates in the immediate future,
manual and paper-based patient care and nursing-sensitive quality
processes and data collection must rapidly transition to electronic
systems."
"Upon completion of the ROI analysis, this is yet another
significant milestone for the commercial release and sales of our
QualOptima product. Our strategy is to introduce transformative
tools that improve care and reduce costs as innovators in the
private enterprise sector," said Feazell.
ABOUT QUTURE INTERNATIONAL, INC. (www.quture.com)
Quture International, Inc. is an emerging growth company
positioned to become the leading clinical knowledge company in the
world. The core competence of Quture is clinical performance
enhancement to achieve optimal patient outcomes. Quture's brand is
centered on the value proposition of trust, transparency and
independence. As the free enterprise solution to improving health
and health care while reducing costs, Quture is comprised of a
subsidiaries in North America and
Europe for the operations of its
software technology solutions, plans for a "beyond data" consulting
and knowledge applications company, as well as plans for a
personalized, proactive, and predictive medicine company with a
virtual community of members. These subsidiaries will all be
affiliated with the Qx Medical Exchange, which the Company intends
to become the largest medical and health exchange in the world.
Quture International is a Nevada
corporation currently trading under the symbol TCLN.
This release contains forward-looking statements, including,
without limitation, statements concerning our business and possible
or assumed future results of operations. Our actual results could
differ materially from those anticipated in the forward-looking
statements for many reasons including: our ability to continue as a
going concern, adverse economic changes affecting markets we serve;
competition in our markets and industry segments; our timing and
the profitability of entering new markets; greater than expected
costs, customer acceptance of our products or difficulties related
to our integration of the businesses we may acquire; and other
risks and uncertainties as may be detailed from time to time in our
public announcements and SEC filings. Although we believe the
expectations reflected in the forward-looking statements are
reasonable, they relate only to events as of the date on which the
statements are made, and our future results, levels of activity,
performance or achievements may not meet these expectations. We do
not intend to update any of the forward-looking statements after
the date of this document to conform these statements to actual
results or to changes in our expectations, except as required by
law. There is no assurance that a definitive agreement will be
completed.
For Further Information Contact:
Constellation Asset Advisors, Inc.
Jens Dalsgaard
President
+1 (415) 524-8500
Contact: Mele Telitz,
Director of Communications
303-204-4486; mele@quture.com
SOURCE Quture International, Inc.